Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05692388 · ClinicalTrials.gov registry record
Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
A clinical trial of Diabetes Mellitus, Type 2 and Chronic Kidney Diseases, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 330
- Enrollment target
- 1
- Study location
NCT05692388: Recruiting study of Diabetes Mellitus, Type 2 and Chronic Kidney Diseases, sponsored by Medical College of Wisconsin.
NCT05692388 is a study of Diabetes Mellitus, Type 2 and Chronic Kidney Diseases that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 330 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05692388, a study of Diabetes Mellitus, Type 2 and Chronic Kidney Diseases, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 330 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve clinical outcomes, quality of life (QOL), and self-care behaviors in African American adults with diabetic kidney disease (DKD) experiencing health-related social needs (HRSN).
Primary Outcome
Blood pressure readings will be obtained using automated BP monitors
Conditions Studied
Interventions
- OTHER Patient and Community Stakeholder Interviews
- OTHER Cross-sectional Study Participants
- OTHER Focus Groups and Intervention Mapping
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2023-01-23 |
| Est. Completion | 2026-03 |
What NCT05692388 shows while recruiting
NCT05692388 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Patient and Community Stakeholder Interviews is the first listed.
NCT05692388 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05692388 about?
NCT05692388 is a clinical study titled "Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus". The overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve clinical outcomes, quality of life (QOL), and self-care behaviors in African American adults with diabetic kidney disease (DKD) experiencing he...
What is the current status of trial NCT05692388?
This trial is currently recruiting. The enrollment target is 330 participants. The study started on 2023-01-23. Estimated completion is 2026-03.
What conditions does trial NCT05692388 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Chronic Kidney Diseases, Diabetic Nephropathy Type 2 - Uncontrolled.
What interventions are being tested in trial NCT05692388?
The interventions under investigation include: Patient and Community Stakeholder Interviews (OTHER), Cross-sectional Study Participants (OTHER), Focus Groups and Intervention Mapping (OTHER).
Who is sponsoring clinical trial NCT05692388?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05692388 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05692388's enrollment target sits among peer trials
330 112th of 348 higher than 237 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI